Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by STOFFERS, H. E J H
Right arrow Articles by KNOTTNERUS, J A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STOFFERS, H. E J H
Right arrow Articles by KNOTTNERUS, J A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press

research-article

The Prevalence of Asymptomatic and Unrecognized Peripheral Arterial Occlusive Disease

HENRI E J H STOFFERS*, PAULA E L M RINKENS*, ARNOLD D M KESTER{dagger}, VICTOR KAISER* and J ANDRÉ KNOTTNERUS*

* Department of General Practice, University of Limburg PO Box 616, NL-6200 MD Maastricht, The Netherlands.
{dagger} Department of Methodology and Statistics. University of Limburg PO Box 616, NL-6200 MD Maastricht, The Netherlands.

BACKGROUND: The prevalence of peripheral arterial occlusive disease (PAOD), including asymptomatic cases and cases unknown to the general practitioner (GP) was estimated in 18 884 men and women, aged 45–74 years, on the list of 18 general practice centres (GPC).

METHODS: The study population (n = 3171) consisted of a stratified sample of the total population. In the GPC data were collected on intermittent claudication (IC), peripheral pulses, vascular risk factors, cardio- and cerebrovascular disease (CCVD) and the ankle brachial systolic pressure ratio (AB ratio) and PAOD was defined as an AB ratio <0.95 on two consecutive occasions. Results were recalculated for the total population.

RESULTS: The prevalence of PAOD was 6.9% (95% confidence interval [CI]: 5.7–8.2%) of which one-third (2.2%) had an AB ratio <0.75. The prevalence of IC was 6.6% (95% CI: 5.2–7.9%), a quarter of which (1.6%) met the classic WHO criteria Peripheral arterial occlusive disease did not occur significantly more often among men than among women but men suffered more often from an advanced stage of PAOD. Of all PAOD cases, 22% were symptomatic. The proportion of symptomatic cases correlated positively with higher age, male gender and lower AB ratio. Among asymptomatic PAOD cases the prevalence of concomitant CCVD was three to four times as high as in the group of subjects without PAOD. Of all PAOD cases 88% were unknown to the GP and this group mainly represented less advanced cases of atherosclerosis. However, among PAOD cases with an AB ratio <0.75, 42% were unknown to the GP.

CONCLUSIONS: Our data on asymptomatic and unknown PAOD cases show that GPs can still enhance their efforts towards (secondary) prevention of atherosclerosis.

Keywords peripheral arterial occlusive disease, Intermittent claudication, non-invasive testing, epidemiology, general practice, prevalence

Revised 1 July 1995


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
R. Schernthaner, D. Fleischmann, A. Stadler, M. Schernthaner, J. Lammer, and C. Loewe
Value of MDCT Angiography in Developing Treatment Strategies for Critical Limb Ischemia
Am. J. Roentgenol., May 1, 2009; 192(5): 1416 - 1424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Lin, Z.-Q. Zhang, J.-Y. Sun, Z.-M. Fan, and B. Lu
Low Injection Rate for 3D Moving-Table Bolus-Chase MR Angiography: Initial Experience with 3-T Imaging to Allay Venous Contamination in the Calf
Am. J. Roentgenol., December 1, 2008; 191(6): 1734 - 1739.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
G. Brevetti, G. Giugliano, G. Oliva, S. Lanero, J.I. De Maio, and M. Chiariello
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study
QJM, July 1, 2008; 101(7): 575 - 582.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Conte
Buflomedil in Peripheral Arterial Disease: Trials and Tribulations
Circulation, February 12, 2008; 117(6): 717 - 719.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
P. Sritara, C. Sritara, M. Woodward, S. Wangsuphachart, F. Barzi, B. Hengprasith, and T. Yipintsoi
Prevalence and Risk Factors of Peripheral Arterial Disease in a Selected Thai Population
Angiology, November 1, 2007; 58(5): 572 - 578.
[Abstract] [PDF]


Home page
Am. J. Roentgenol.Home page
R. Schernthaner, D. Fleischmann, F. Lomoschitz, A. Stadler, J. Lammer, and C. Loewe
Effect of MDCT Angiographic Findings on the Management of Intermittent Claudication
Am. J. Roentgenol., November 1, 2007; 189(5): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Golomb, T. T. Dang, and M. H. Criqui
Peripheral Arterial Disease: Morbidity and Mortality Implications
Circulation, August 15, 2006; 114(7): 688 - 699.
[Full Text] [PDF]


Home page
Vasc MedHome page
V. Schiano, G. Brevetti, G. Sirico, A. Silvestro, G. Giugliano, and M. Chiariello
Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study
Vascular Medicine, August 1, 2006; 11(3): 147 - 154.
[Abstract] [PDF]


Home page
Vasc MedHome page
W. R Hiatt and M. J Krantz
Masterclass series in peripheral arterial disease: Antiplatelet therapy for peripheral arterial disease and claudication
Vascular Medicine, February 1, 2006; 11(1): 55 - 60.
[Abstract] [PDF]


Home page
JAMAHome page
G. J. Hankey, P. E. Norman, and J. W. Eikelboom
Medical Treatment of Peripheral Arterial Disease
JAMA, February 1, 2006; 295(5): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
R. A. Mangiafico, F. Sarnataro, M. Mangiafico, and C. E. Fiore
Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels
Age Ageing, January 1, 2006; 35(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Criqui, V. Vargas, J. O. Denenberg, E. Ho, M. Allison, R. D. Langer, A. Gamst, W. P. Bundens, and A. Fronek
Ethnicity and Peripheral Arterial Disease: The San Diego Population Study
Circulation, October 25, 2005; 112(17): 2703 - 2707.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Kennedy, C. Solomon, T. A. Manolio, M. H. Criqui, A. B. Newman, J. F. Polak, G. L. Burke, P. Enright, and M. Cushman
Risk Factors for Declining Ankle-Brachial Index in Men and Women 65 Years or Older: The Cardiovascular Health Study
Arch Intern Med, September 12, 2005; 165(16): 1896 - 1902.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
P. Lind, B. Hedblad, L. Stavenow, G. Engstrom, L. Janzon, M. Ogren, and F. Lindgarde
Incidence of Myocardial Infarction and Death in Relation to Walking-Induced Calf Pain and Plasma Levels of Inflammation-Sensitive Proteins
Angiology, September 1, 2005; 56(5): 507 - 516.
[Abstract] [PDF]


Home page
Diabetes CareHome page
C. L. Leibson, J. E. Ransom, W. Olson, B. R. Zimmerman, W. M. O'Fallon, and P. J. Palumbo
Peripheral Arterial Disease, Diabetes, and Mortality
Diabetes Care, December 1, 2004; 27(12): 2843 - 2849.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. J. F. Belch
Cost-effective, Risk-Free, Evidence-Based Medicine--Reply
Arch Intern Med, December 8, 2003; 163(22): 2795 - 2796.
[Full Text] [PDF]


Home page
Med Decis MakingHome page
J. D. Hooi, H. E.J.H. Stoffers, A. D. M. Kester, J. W. van Ree, and J. A. Knottnerus
Peripheral Arterial Occlusive Disease: Prognostic Value of Signs, Symptoms, and the Ankle-Brachial Pressure Index
Med Decis Making, April 1, 2002; 22(2): 99 - 107.
[Abstract] [PDF]


Home page
Diabetes CareHome page
E. B. Jude, S. O. Oyibo, N. Chalmers, and A. J.M. Boulton
Peripheral Arterial Disease in Diabetic and Nondiabetic Patients: A comparison of severity and outcome
Diabetes Care, August 1, 2001; 24(8): 1433 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. D. Hooi, A. D. M. Kester, H. E. J. H. Stoffers, M. M. Overdijk, J. W. van Ree, and J. A. Knottnerus
Incidence of and Risk Factors for Asymptomatic Peripheral Arterial Occlusive Disease: A Longitudinal Study
Am. J. Epidemiol., April 1, 2001; 153(7): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. C. D. Westendorp, B. A. in't Veld, D. E. Grobbee, H. A. P. Pols, W. T. Meijer, A. Hofman, and J. C. M. Witteman
Hormone Replacement Therapy and Peripheral Arterial Disease: The Rotterdam Study
Arch Intern Med, September 11, 2000; 160(16): 2498 - 2502.
[Abstract] [Full Text]


Home page
StrokeHome page
M. Matteis, E. Troisi, B. C. Monaldo, C. Caltagirone, and M. Silvestrini
Age and Sex Differences in Cerebral Hemodynamics : A Transcranial Doppler Study
Stroke, May 1, 1998; 29(5): 963 - 967.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. T. Meijer, A. W. Hoes, D. Rutgers, M. L. Bots, A. Hofman, and D. E. Grobbee
Peripheral Arterial Disease in the Elderly : The Rotterdam Study
Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
H. E.J.H. Stoffers, A. D.M. Kester, V. Kaiser, P. E.L.M. Rinkens, and J. A. Knottnerus
Diagnostic Value of Signs and Symptoms Associated with Peripheral Arterial Occlusive Disease Seen in General Practice: A Multivariable Approach
Med Decis Making, February 1, 1997; 17(1): 61 - 70.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.